Brain Scientific Inc.
BRSF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $95 | $6,779 | $20,973 | $15,043 |
| - Cash | $748 | $785 | $69 | $261 |
| + Debt | $2,863 | $10,651 | $761 | $879 |
| Enterprise Value | $2,211 | $16,644 | $21,666 | $15,660 |
| Revenue | $215 | $266 | $94 | $489 |
| % Growth | -19.3% | 183.7% | -80.9% | – |
| Gross Profit | $54 | $83 | $50 | $102 |
| % Margin | 25.3% | 31.3% | 53.3% | 20.9% |
| EBITDA | -$7,934 | -$8,323 | -$2,752 | -$969 |
| % Margin | -3,697.6% | -3,132% | -2,938.3% | -198% |
| Net Income | -$12,344 | -$9,101 | -$2,803 | -$1,004 |
| % Margin | -5,753% | -3,424.6% | -2,992.6% | -205.2% |
| EPS Diluted | -12.95 | -25.21 | -8.88 | -4.44 |
| % Growth | 48.6% | -183.9% | -100% | – |
| Operating Cash Flow | -$5,935 | -$5,867 | -$932 | -$855 |
| Capital Expenditures | -$33 | -$59 | -$30 | -$1 |
| Free Cash Flow | -$5,968 | -$5,925 | -$962 | -$856 |